Status:
COMPLETED
Retrospective Real-Life Study From One Brazilian Reference Center Assessing Long-Term Experience In The Treatment Of Adult Spasticity With AbobotulinumtoxinA
Lead Sponsor:
Ipsen
Conditions:
Spasticity
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to describe the long-term use of abobotulinumtoxinA (Dysport®) in adult subjects affected with upper limb spasticity (ULS) +/- lower limb spasticity (LLS) who received treatmen...
Eligibility Criteria
Inclusion
- Adult aged ≥18 years old at the time of the first Dysport® injection
- Diagnosed with spasticity
- Treated with a minimum of three Dysport® injection cycles for ULS +/- LLS in the observational period
- Follow up effectiveness data are available in the subject's medical record
Exclusion
- Patients have received previous treatment with another BoNT-A less than 12 weeks prior to the patient data collection in the study
- Adults with cerebral palsy
- Patients treated with BoNT-A in a clinical trial setting
Key Trial Info
Start Date :
March 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 10 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04446702
Start Date
March 5 2021
End Date
December 10 2021
Last Update
December 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto de Medicina Física e Reabilitação do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (IMREA HC FMUSP)
São Paulo, Brazil